BioTrinity 2025

BioTrinity is OBN’s flagship two-day conference for the life sciences industry, designed to catalyse growth for all who attend. The two-day conference programme for 2025 will feature a dual track of showcase presentations from R&D companies at around the Series A stage, across at least 12 different therapy areas.  There is an expected audience of 850 delegates, comprising a mix of early stage and emerging life sciences R&D companies, investors, big pharma, academics, charities, government, and broad range of valued service providers.